Silver Nanoparticles Enhanced Doxorubicin treatment for Improving their Efficacy against Esophageal Cancer Cells
Moawad, M., Youssef, A., Elsherbeni, S., Fahmy, A., El-Ghannam, G. (2024). Silver Nanoparticles Enhanced Doxorubicin treatment for Improving their Efficacy against Esophageal Cancer Cells. EKB Journal Management System, 67(1), 505-512. doi: 10.21608/ejchem.2023.210101.7955
Mahmoud Moawad; Ahmed M. Youssef; Sayed Abd Elmajied Elsherbeni; Ahmed M. Fahmy; Gamal El-Ghannam. "Silver Nanoparticles Enhanced Doxorubicin treatment for Improving their Efficacy against Esophageal Cancer Cells". EKB Journal Management System, 67, 1, 2024, 505-512. doi: 10.21608/ejchem.2023.210101.7955
Moawad, M., Youssef, A., Elsherbeni, S., Fahmy, A., El-Ghannam, G. (2024). 'Silver Nanoparticles Enhanced Doxorubicin treatment for Improving their Efficacy against Esophageal Cancer Cells', EKB Journal Management System, 67(1), pp. 505-512. doi: 10.21608/ejchem.2023.210101.7955
Moawad, M., Youssef, A., Elsherbeni, S., Fahmy, A., El-Ghannam, G. Silver Nanoparticles Enhanced Doxorubicin treatment for Improving their Efficacy against Esophageal Cancer Cells. EKB Journal Management System, 2024; 67(1): 505-512. doi: 10.21608/ejchem.2023.210101.7955

Silver Nanoparticles Enhanced Doxorubicin treatment for Improving their Efficacy against Esophageal Cancer Cells

Egyptian Journal of Chemistry
Volume 67, Issue 1, January 2024, Page 505-512  XML PDF (815.79 K)
Document Type: Original Article
DOI: 10.21608/ejchem.2023.210101.7955
View on SCiNiTO View on SCiNiTO
Authors
Mahmoud Moawad1; Ahmed M. Youssef email orcid 2; Sayed Abd Elmajied Elsherbeniorcid 3; Ahmed M. Fahmy1; Gamal El-Ghannam3
1Pathology Dept., National Cancer Institute, Cairo Univ. Egypt,
2Packaging Materials Department, National Research Centre, 33 El Bohouth St. (former El Tahrir St.), Dokki, Giza, P.O. 12622, Egypt.
3National Institute of Laser Enhanced Science (NILES), Cairo University, Giza, Egypt.
Abstract
Silver nanoparticles (SNPs) have shown potential in various biomedical applications, including biological imaging, antimicrobial and anticancer therapy, and promotion of wound repair and bone healing. In this study, we demonstrate the feasible biomedical application of SNPs coated with the FDA-approved anti-cancer drug doxorubicin (DOX) for dual-chemotherapy and photo thermal treatment (PTT) on esophagus tumors in vitro. The synthesized doxorubicin/ silver nanoparticles (DOX-SNPs) exhibited high cytotoxicity against the tumor cells and strong light harvesting for temperature increase in vitro. PTT-assisted DOX-SNPs entailed a highly cytotoxic effect on the esophagus cell line for 15 min after laser treatment, indicating the potential of DOX-SNPs as a nano-theranostic material for treating esophagus tumors. Furthermore, the study investigated gene expression levels in the esophagus cell line after laser exposure and found that the Bax gene was overexpressed, while the BCL-2 gene was down-regulated post-laser irradiation compared to the control group, as determined by RT-PCR analysis. According to the findings of this thesis, the mRNA expression level of pro-apoptotic genes became unregulated, while the expression of anti-apoptotic genes was found to be down regulated, while a higher level of caspase-3 mRNA was observed in SNPs/DOX nanocomposites treated OE33 cells with laser compared to control cells.
Keywords
Silver nanoparticles; Doxorubicin; Laser; photo-thermal therapy; Bax; BCL-2 genes; RT-PCR
Statistics
Article View: 152
PDF Download: 93